Perniosis

 

Salient features

 

·       Cold-sensitive inflammatory disorder in which erythrocyanotic discoloration of acral skin is accompanied by a sensation of itching, burning or pain

 

·       Common trigger is exposure to cold, wet, non-freezing conditions

 

·       Must be distinguished from chilblain lupus and cold-sensitive blood dyscrasias

 

·       Nifedipine can be used to treat moderate to severe pernio

 


Introduction

 

Perniosis is a benign localized inflammatory lesion on the acral skin with erythema and swelling caused by abnormal (exaggerated) reaction to cool temperatures (above freezing) and dampness in genetically susceptible person, typically presenting during winter climate. Pernio may be idiopathic or secondary to an underlying disease. In people predisposed by poor peripheral circulation, even moderate exposure to cold may produce chilblains. Hyperhidrosis and low body mass index are suggested associations.

 

Epidemiology

 

Women, children and the elderly and persons with low body mass index are most commonly affected.  Elderly patients may have a prolonged course, while younger patients improve spontaneously.

 

Environmental factors

 

Perniosis occurs in susceptible individuals during the autumn or winter in a climate that is both cold and damp. Spontaneous remission is common when spring arrives, and relapse is frequent during the following winters. However, chilblains do not always occur at the time of maximum cold.

 

Aetiology

 

The direct cause of pernio is persistent cold exposure; specifically, exposure to both mild non freezing cold and humidity seems to be required. Chronic pernio may be secondary to various systemic diseases as follows:

·        Chronic myelomonocytic leukemia 

·        Anorexia nervosa : Low body mass index may predispose to pernio. 

·        Dysproteinemias

·        Macroglobulinemia

·        Cryoglobulinemia, cryofibrinogenemia, cold agglutinins

·        Antiphospholipid antibody syndrome

·        Raynaud disease 

·        Celiac disease 

 

 

Pathophysiology

 

The precise pathogenesis of pernio is unknown, but the condition is thought to represent an abnormal inflammatory response to vascular ischemia caused by prolonged vasoconstriction in the setting of extended cold exposure.  In perniosis there is a persistent cold-induced vasoconstriction of the deep cutaneous arterioles with concomitant dilatation of the smaller, superficial vessels. This is in contrast with normal subjects, in whom cold exposure induces cutaneous vasoconstriction succeeded by vasodilatation, a homeostatic mechanism necessary for the maintenance of reperfusion. In children, it may be associated with cryoproteins.

 

Clinical features


Patients with chilblains are often unaware of the cold injury when it is occurring, but later burning, pain, itching, and redness call it to their attention. Pernio develop acutely with single or multiple bluish red macules, oedematous papules, plaques or nodules, that appear 12 to 24 hours after prolonged exposure to cool, damp air, the color partially or totally disappearing on pressure, and are decidedly cool to the touch. Sometimes the extremities are clammy because of excessive sweating. In severe cases, blistering and ulceration may be seen. Lesions are more common on the dorsal aspects of the digits. Involvement of the feet is most common, followed by the hands. Lesions are often symmetrically distributed on acral skin, in particular the distal toes and fingers, and less often on the heels, nose, and ears. Overlying scale can also develop. Deep pernio may be seen on the thighs, calves, and buttocks as blue-erythrocyanotic plaques. As long as the damp/ cold exposure continues, new lesions will continue to appear. Each lesion tends to undergo spontaneous resolution after 2–3 weeks but may become chronic in elderly people with venous stasis.

 

Variants include the following:

 

·        Kibes (equestrian cold panniculitis): Erythrocyanotic plaques occur on the upper lateral thighs of women who ride horses. Histology is characterized by an intense perivascular infiltrate extending into subcutaneous fat.

 

·        Chilblain lupus erythematosus:  Chilblain LE (also known as Hutchinson lupus) is a form of cutaneous LE that presents in a similar way to idiopathic perniosis. Erythrocyanotic papules and plaques appear prominent over dorsal interphalangeal joints of the fingers and toes, develop in cold weather and tend to persist, in some cases becoming ulcerated, often with positive antinuclear antibody (ANA) or rheumatoid factor (RF). Histologic and immunofluorescent evidence of lupus is present in the skin lesions. Half of the patients have associated facial discoid lupus lesions, and 15% develop systemic lupus.

 

 

Pathology

 

Pernio can often be diagnosed on the basis of clinical findings. Biopsy may be indicated to rule out other inflammatory processes in difficult chronic cases. Punch biopsy is adequate. Idiopathic perniosis is characterized histologically by intense oedema of the papillary dermis and by the presence of superficial and deep perivascular lymphocytic infiltrates, with peri-eccrine accentuation. The infiltrate is composed predominantly of T lymphocytes. Necrotic keratinocytes and lymphocytic vasculitis may also be present. Thickening of blood vessel walls with intimal proliferation may lead to obliteration of the vascular lumen.

 

 

Prognosis

 


Prognosis is good. Recurrences may be observed annually with onset of cold weather.  Long-term follow-up of patients with chronic recurrent pernio is advised because this may reveal connective-tissue disease (lupus erythematosus). Most cases of pernio resolve without any adverse reactions when steps are taken to prevent cold exposure. Idiopathic chilblains are rarely associated with joint inflammation, and the presence of arthritis should prompt consideration for multisystem disease.

 

 

Investigations

 

All patients with perniosis should undergo a detailed history, review of systems, and physical examination with or without a skin biopsy based on the degree of clinical certainty. Laboratory workup should be conducted only if the clinical presentations suggest a possible underlying systemic disease. Pernio demonstrating a chronic course (continuous for at least 4 weeks and, in some cases, 8 weeks or longer, or episodic in nature), persistence into warm weather months, and onset in the elderly may be suggestive of an associated connective tissue disease, haematological malignancy, or other systemic condition.

 

The following laboratory tests may be needed:

·        CBC count and sedimentation rate: These should be obtained to rule out associated leukemia.

·        Antiphospholipid antibody panel: Review of patients presenting with pernio shows an increased incidence of antiphospholipid antibody syndrome.

·        Cryoglobulins, cryofibrinogen, and cold agglutinin testing: These generally are absent but should be considered as part of the laboratory evaluation in a patient with chronic pernio. Because of occasional false-negative cryoprecipitate screening results, consider hepatitis C antibody screening or even rheumatoid factor (RF) as a marker for cryoglobulinemia in select cases.

·        Antinuclear antibody (ANA): Pernio lesions can occur in the setting of lupus erythematosus.

·        Serum protein electrophoresis (SPEP) and quantitative immunoglobulins: Dysproteinemias and macroglobulinemia, causing increased serum viscosity, may be associated with pernio.

 

 

Treatment

 

The most important point in management is prophylaxis through the use of adequate, loose, insulating clothing and appropriate warm housing and workplace. The affected parts should be protected against further exposureto cold and dampness. If the feet are affected, woolen socks should be worn at all times during the cold months. Keep feet dry. Moisture enhances cold injury. For perniosis of the hands, gloves are recommended. Use electrical or other hand warmers. Tight garments, such as s gloves, stockings, and shoes, are especially to be avoided in cases in which there is concomitant peripheral vascular disease.  Maintaining the blood circulation by avoiding immobility is also helpful. Because patients are often not conscious of the cold exposure that triggersthe lesions, appropriate dress must be stressed, even if patients say they do not sense being cold. Since central cooling triggers peripheral vasoconstriction, keeping the whole body (not just the affected extremity) warm is critical. Heating pads may be used judiciously to warm the parts.

 

Once chilblains occur, treatment is symptomatic with rest and warmth. Other conservative measures include smoking cessation and application of mid potency topical steroid twice daily until the lesions heal. Associated systemic disease, if present, should be treated.

 

Second line therapy of pernio consists of the addition of a calcium channel blocker, such as nifedipine 20-60 mg daily or diltiazem 60-120mg three times daily. It is effective in about 70% of patients, in both clearing existing pernio lesions and in preventing the development of new lesions. This efficacy is due to the vasodilatory effect of this medication. While mild symptoms of peripheral oedema and hypotension may occur, these symptoms rarely require discontinuation of the medication when used at low doses. Monitor blood pressure at the start of treatment and at return visits.

 

Amlodipine 2.5–5 mg once daily may be used as an alternative calcium channel blocker. The long half-life and consequent once daily dosing of this drug is beneficial when chronic therapy is required.

 

Third line and alternative management options include vasodilators such as nicotinamide, 500 mg three times a day, or dipyridamole, 25 mg three times a day, or the phosphodiesterase inhibitor sildenafil, 50 mg twice daily, may be used to improve circulation. Pentoxifylline 400mg bid or tid is probably the safest approach. Topical minoxidil, topical 0.2% nitroglycerin and topical tacrolimus are also used.

 

Systemic corticoid therapy is useful in chilblain lupus erythematosus.

 

 

Preventing chilblains

 

The following advice may help prevent chilblains:

·        Stop smoking. Nicotine causes the blood vessels to constrict (get narrower), which can make chilblains worse.

·        Avoid medicines that may constrict blood vessels, such as caffeine and decongestants.

·        Keep active. This helps improve your circulation.

·        Wear warm clothes and insulate your hands, feet, and legs. Wearing long johns, long boots, tights, leg warmers or long socks will help. If you get cold feet in bed, wear a pair of clean socks.

·        Avoid tight shoes and boots as these can restrict the circulation to toes and feet.

·        Moisturize your feet regularly. This stops them from drying out and the skin cracking.

·        In cold weather, eat at least one hot meal during the day. This will help warm your whole body.

·        Warm your shoes on the radiator before you put them on. Make sure damp shoes are dry before wearing them.

·        Warm your hands before going outdoors by soaking them in warm water for several minutes and drying them thoroughly. Wear cotton-lined waterproof gloves if necessary.

·        Turn up the central heating. Try to keep one room in the house warm and avoid drafts.

 

 

Popular Posts